Thyroid Accumulation of 99m Tc-DTPA in Graves Disease.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
medline:
24
11
2023
pubmed:
13
9
2023
entrez:
13
9
2023
Statut:
ppublish
Résumé
99m Tc-DTPA dynamic renal scintigraphy for evaluating glomerular filtration rate was performed in a 29-year-old woman with hyperuricemia and Graves disease. Subsequently, 99m Tc-DTPA orbital scintigraphy was conducted to determine the activity of Graves ophthalmopathy. Thyroid accumulation of 99m Tc-DTPA was incidentally identified. This should be cautiously distinguished from 99m Tc-pertechnetate uptake, considering that the salivary glands, oral cavity, and stomach were not visualized. Our case demonstrates that augmentation of blood supply, enhancement of capillary permeability, and accumulation of inflammatory exudate may be involved in the pathological process of Graves disease.
Identifiants
pubmed: 37703477
doi: 10.1097/RLU.0000000000004858
pii: 00003072-202311000-00045
doi:
Substances chimiques
Technetium Tc 99m Pentetate
VW78417PU1
Radiopharmaceuticals
0
Technetium
7440-26-8
Sodium Pertechnetate Tc 99m
A0730CX801
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e552-e553Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Agrawal G, Siegel BA. Serendipitous diagnosis of hyperthyroidism on pulmonary perfusion scintigraphy. Clin Nucl Med . 2011;36:819–820.
Liu Y, Tong G, Wen Z, et al. Hyperthyroidism incidentally noted on lymphoscintigraphy. Clin Nucl Med . 2021;46:761–763.
Warwick J, Holness J. Measurement of glomerular filtration rate. Semin Nucl Med . 2022;52:453–466.
Wang T, Zhao J, Xing Y, et al. Uptake of 99m Tc-DTPA in bone metastases from renal cancer. Clin Nucl Med . 2015;40:840–841.
Pilecki S, Gierach M, Pufal J, et al. Accumulation of Tc-99m DTPA in Ewing sarcoma. Clin Nucl Med . 2005;30:771–772.
Larcos G, Gruenewald SM, Farlow DC, et al. Tc-99m DTPA uptake in Paget's disease of the left ilium. Clin Nucl Med . 1990;15:22–24.
Liu D, Xu X, Wang S, et al. 99m Tc-DTPA SPECT/CT provided guide on triamcinolone therapy in Graves' ophthalmopathy patients. Int Ophthalmol . 2020;40:553–561.
Szabados L, Nagy EV, Ujhelyi B, et al. The impact of 99m Tc-DTPA orbital SPECT in patient selection for external radiation therapy in Graves' ophthalmopathy. Nucl Med Commun . 2013;34:108–112.
Alevizaki-Harhalak M, Alevizaki C, Georgiou E, et al. Increased Tc-99m DTPA uptake in active Graves' ophthalmopathy and pretibial myxoedema. J Nucl Med . 1983;24:174–176.
Ujhelyi B, Erdei A, Galuska L, et al. Retrobulbar 99m Tc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in Graves' ophthalmopathy. Thyroid . 2009;19:375–380.